text
"['\nIX. 계열회사 등에 관한 사항\n1. 기업집단의 명칭\xa0- 대웅그룹 - 공정거래법상 상호출자 제한, 출자총액 제한, 채무보증 제한에 해당하지 않습니다2. 기업집단의 소속회사의 명칭\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0\n구분\n회사명\n주업종\n비고\n상장법인\n(주)대웅\n지주회사(기타서비스업)\n지주회사\n(주)대웅제약\n의약품제조 및 판매\n자회사\n한올바이오파마(주)\n의약품제조 및 판매\n손자회사\n비상장법인\n대웅바이오(주)\n원료의약품 제조 및 판매\n자회사\n(주)대웅생명과학\n식품 가공업 및 판매업\n〃\n(주)대웅경영개발원\n경영 및 산업연수사업\n〃\n(주)산웅개발\n용역업\n〃\n(주)대웅이엔지\n공무, 시설관리 용역업\n〃\n(주)팜팩\n의약외품의 포장업\n〃\n(주)대웅개발\n부동산 임대 및 공급업\n〃\n(주)아이디에스앤트러스트\n통신관련 기기의 제조 및 판매업\n〃\n㈜에이치알그룹\n리더십교육, 코칭, HR컨설팅, 솔루션\n〃\n(주)일루미네이드\n3D프린터, 광학기계\n〃\n㈜에스티에이치이솔루션\n구강위생용품 개발 및 판매\n〃\n(주)대웅테라퓨틱스\n신규 의약 기술개발\n〃\n(주)힐리언스\n생활습관병 예방 및 연구업\n손자회사\n다나아데이터㈜\n응용소프트웨어 개발 및 공급업\n〃\n(주)엠디웰아이엔씨\n환자식 제조판매\n〃\n농업회사법인(주)대웅낙원\n농지임대 및 매매\n〃\nDaewoong Pharma PHILIPPINES INC.\n의약품 수출입 및 판매\n해외법인\n북경대웅위업의약과기유한공사\n의약품 연구개발, 기술이전, 기술개발\n〃\nDaewoong Pharmaceutical(Thailand)Co.,Ltd\n의약품 수출입 및 판매\n〃\nDaewoong America, Inc.\n의약품 수출입 및 판매\n〃\nPT. Daewoong Pharmaceutical(Indonesia)Co.Ltd\n의약품 수출입 및 판매\n〃\n사천대웅생물기술유한공사\n연구개발\n〃\nDAEWOONG PHARMACEUTICAL HONGKONG\n지주회사\n〃\nDaewoong Pharmaceutical India Pvt.,Ltd\n의약품 수출입 및 판매\n〃\nDaewoong Pharmaceutical Japan Co., Ltd.\n의약품 판매\n〃\nHPI,INC\n해외임상 진행 및 라이센싱아웃 업무\n〃\n요녕대웅제약유한공사\n의약품 제조 및 판매\n〃\nPT. DAEWOONG INFION\n의약품 제조 및 판매\n〃\nDaewoong Bio Indonesia\n의약품 원료\n〃\n계\n32개사\n-\n-\n3. 계열회사간 출자현황\n계열회사간출자현황(2019.12)\n4.회사와 계열회사간 임원 겸직 현황\n겸\xa0\xa0 직\xa0\xa0 임\xa0\xa0 원\xa0\n겸\xa0 \xa0\xa0 직\xa0 \xa0\xa0 회\xa0 \xa0 사\xa0\n비\xa0 \xa0\xa0 고\xa0\n성\xa0 명\xa0\n직\xa0 \xa0 \xa0 위\xa0\n회\xa0 사\xa0 명\xa0\n직\xa0 \xa0 \xa0 위\xa0\n윤재춘\n대표이사\n대웅\n대표이사\n-\n한올바이오파마\n대표이사\n대웅개발\n대표이사\n-\n대웅바이오\n대표이사\n-\n5. 타법인출자 현황\n(기준일 :\xa0\n2019년 12월 31일\n)\n(단위 : 천원, 주, %)\n법인명\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n한올바이오파마(주) (상장)\n-\n인수\n104,020,000\n15,672,192\n30\n106,111,335\n-\n-\n-\n15,672,192\n30\n106,111,335\n189,680,775\n19,000,569\n힐리언스 (비상장)\n-\n인수\n800,000\n2,753,300\n76\n20,919,236\n-\n-\n-2,254,414\n2,753,300\n76\n18,664,822\n32,848,339\n-2,076,287\nDaewoong Pharma PHILIPPINES, INC. (비상장)\n-\n설립\n54,483\n-\n100\n260,539\n-\n-\n-\n-\n100\n260,539\n3,425,202\n263,067\nDaewoong Pharmaceutical(Thailand)Co.,Ltd (비상장)\n-\n설립\n61,294\n-\n100\n205,389\n-\n-\n-\n-\n100\n205,389\n2,884,413\n406,099\nPT. DAEWOONG PHARMACEUTICAL COMPANY INDONESIA (비상장)\n-\n설립\n959,423\n-\n100\n7,812,111\n-\n-\n-\n-\n100\n7,812,111\n3,266,177\n-2,689,592\nDAEWOONG PHARMACEUTICAL HONGKONG (비상장)\n-\n설립\n17,660,725\n269,255,424\n90\n37,809,184\n-\n-\n-\n269,255,424\n90\n37,809,184\n0\n0\n북경대웅위업의약과기유한공사 (비상장)\n-\n설립\n99,953\n-\n100\n6,036,200\n-\n2,066,732\n-2,042,264\n-\n100\n6,060,668\n4,243,443\n-501,080\n바이오시네틱스 (비상장)\n-\n사업관련\n2,000,000\n645,000\n18\n819,086\n-\n-\n-\n645,000\n18\n819,086\n3,529,988\n-1,286,230\n이피피미디어 (비상장)\n-\n사업관련\n1,000,000\n100,000\n20\n-\n-\n-\n-\n100,000\n20\n-\n7,717,728\n-1,401,917\n엠디웰아이엔씨 (비상장)\n-\n설립\n500,000\n100,000\n50\n500,000\n-\n-\n-\n100,000\n50\n500,000\n7,716,169\n860,795\nDaewoong America, Inc. (비상장)\n2009.12.30\n설립\n117,111\n-\n100\n83,286\n-\n-\n-\n-\n100\n83,286\n31,608\n-6,088\nDaewoong Pharmaceutical India Pvt.,Ltd (비상장)\n-\n설립\n67,478\n-\n100\n185,074\n-\n365,659\n-\n-\n100\n550,733\n527,246\n-9,580\nDAEWOONG PHARMACEUTICAL JAPAN CO.,LTD\n2017.03.08\n설립\n555,621\n1,100\n100\n555,621\n-\n-\n-\n1,100\n100\n555,621\n17,919,846\n-294,310\n건강한삶기술창업벤처PEF\n2018.03.19\n설립\n1,500,000\n1,500,000,000\n49\n1,500,000\n-\n-\n-\n1,500,000,000\n49\n1,500,000\n2,804,412\n-124,931\n㈜다나아데이터\n2018.11.23\n설립\n5,100,000\n102,000\n51\n5,100,000\n-\n-\n-\n102,000\n51\n5,100,000\n9,988,114\n54,156\nImmplacate, Inc.\n2019.03.08\n사업관련\n-\n-\n-\n-\n1,428,571\n1,125,970\n1,428,571\n20\n1,125,970\n256,710\n-954,266\n진켐 (비상장)\n-\n사업관련\n500,000\n41,932\n3\n114,516\n41,932\n3\n114,516\n17,124,130\n-6,055,033\n바이오넷 (비상장)\n2001.12.22\n사업관련\n700,000\n129,795\n6\n975,668\n-97,347\n-4\n-239,451\n32,448\n6\n736,213\n12,313,691\n-9,727,182\n큐어바이오 (비상장)\n-\n사업관련\n999,902\n3,111\n2\n350,641\n-12,774\n3,111\n2\n337,867\n14,679,740\n-2,611,514\n3D Matrix (해외상장)*\n-\n사업관련\n1,362,230\n320,000\n2\n1,115,309\n511,375\n320,000\n2\n1,626,684\n3,020,843\n1,965,654\n카이페리온\n2019.10.16\n28,572\n1,000,020\n28,572\n3\n1,000,020\n5,262,307\n1,050,802\nJTBC (비상장)\n-\n단순투자\n3,000,000\n600,000\n1\n347,400\n-99,600\n600,000\n1\n247,800\n284,337,991\n-25,059,448\n향남제약공단 (비상장)\n-\n단순투자\n34,156\n-\n-\n217,879\n-\n-\n217,879\n0\n0\n자일자동차판매 (비상장)\n-\n단순투자\n639,011\n-\n0\n278,272\n43,378\n-\n0\n321,650\n260,338,749\n3,912,415\n대우산업개발 (비상장)\n-\n단순투자\n426,192\n-\n1\n26,803\n-\n1\n26,803\n265,820,813\n10,472,043\n합 계\n-\n0\n191,323,549\n1,359,796\n4,558,377\n-4,093,750\n-\n0\n191,788,176\n1,149,738,434\xa0\n-14,811,858\n* 3D Matrix는 19년 4월말 재무제표이며 단위는 천엔입니다.\n']"
